Brussels - Delayed Quote EUR

Gimv NV (GIMB.BR)

Compare
40.15 +0.65 (+1.65%)
At close: 5:35:17 PM GMT+1

Key Executives

Amounts are as of December 31, 2024 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.
NameTitlePayExercisedYear Born
Mr. Koen Dejonckheere Eng., M.B.A., M.Sc. CEO & Director -- -- 1969
Mr. Kristof Vande Capelle Chief Financial Officer -- -- 1969
Mr. Edmond Bastijns Chief Legal Officer & Secretary General -- -- 1973
Mr. Vincent Van Bueren Corporate Communications & Sustainability Manager -- -- --
Mr. Patrick Van Beneden FMedSci., FRCP, FRCR, FRSE, M.D., Sc Associate Partner -- -- 1962
Dr. Bart Diels Ph.D. Managing Partner & Head of Healthcare -- -- 1969
Mr. Elderd Land Partner & Head of Gimv -- -- 1967
Mr. Tom Van de Voorde Managing Partner & Head of Smart Industries -- -- 1971
Mr. Rombout Poos CPA Partner -- -- 1968
Mr. Nick Medaer Partner -- -- 1984

Gimv NV

Karel Oomsstraat 37
Antwerp, 2018
Belgium
32 3 290 21 00 https://www.gimv.com/en/
Industry: 
Asset Management
Full Time Employees: 
93

Description

Gimv NV is a private equity and venture capital firm specializing in direct and fund of funds investments. For direct investments, the firm specializes in buyouts, growth capital, middle market, debt, shareholder loans, seed, startups, early to mid-stage, late venture, public to private transactions, small and medium sized enterprises, later stage, mature, replacement capital, bridge financing, and recapitalization. Within fund of funds, it seeks to invest in venture capital and private equity funds. It seeks to invest in high performance growth companies that respond to that can speed up their internal growth through acquisitions. The firm typically invests in consumer, connected consumer, fintech; health and care; smart industries; and sustainable cities. Within consumer, it seeks to provide growth capital to emerging leaders. Within health and care platform, the firm seeks to invest in companies that can grow either organically or through a buy and build strategy. Within consumer, it focuses on consumer goods, food and beverage, healthy food, sport, convenience food, personal luxury, career, home & deco, baby & kids, pet products, retail, consumer services, media and content, travel and leisure, education, digital economy and online sectors. Within health and care sector, it focuses on life sciences, medtech, and health and care services. The firm focuses on biotech/biopharma comprising drugs, platform technologies, vaccines and diagnostic tests, preclinical, early clinical, and late clinical, medtech such as medical devices, consumables, IT and small equipment, and health and care services-based companies. It also seeks to be an active shareholder, preferably lead or co-lead in its investments. Within smart industries, it focuses on equipment, services and tools for resource efficient development and production, automotive and aerospace, both optimizing of the existing and development of new means of transport, software and services harnessing the flexibility of the cloud, smart data management and advanced computation power, and components and systems for efficient use of energy, in terms of production, storage, management, use and transport sectors. It focuses on B2B products and services, based on innovation, advanced engineering, advanced manufacturing or software. It also makes flexible equity investment (equity, semi-equity, minority or majority) but always with a meaningful impact on the company and an exit trigger. Within sustainable cities, it focuses on Products, services and infrastructure for building sustainable urban societies: Utilities and consumer goods related to energy and other (raw) materials, Waste treatment, recycling and recovery, Construction and Infrastructure, Transport and Logistics Services, and biomass, green (sustainable) chemistry, water, offshore and maritime solutions and energy efficient infrastructure. It invests through (mezzanine, equity, minority or majority) but will always strive to have a meaningful impact on the company strategy and need an exit trigger. It also invests in semiconductors, chemicals, agriculture, clean technology, electronics, water processing and purification technologies. It mainly focuses on European market and midcap companies in Flanders and Brussels, and also invests in Kazakhstan, Benelux, Germany, France, Italy, Luxembourg, Netherlands, United Kingdom, Russia, Czech Republic, and Slovakia and invests in small and medium sized businesses primarily with headquarters in the Benelux, France, and Germany. It typically makes investments between €5 million ($5.43 million) to €75 million ($81.53 million) in consumer, health care, smart industries and sustainable client sector. It may take a majority or a minority stake in its portfolio companies. Its investment horizon is between four and seven years. It also seeks a board seat in its portfolio companies. It invests with capital from its own balance sheet and through various funds under management. Gimv NV was founded on February 25, 1980 and is based in Antwerp, Belgium with additional offices in Paris, France; Hague, The Netherlands; Frankfurt am Main, Germany; London, United Kingdom; Prague, Czech Republic; Warsaw, Poland; and Munich, Germany.

Corporate Governance

Gimv NV’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

November 21, 2024 at 10:59 AM UTC

Gimv NV Earnings Date

Recent Events

July 1, 2024 at 12:00 AM UTC

Ex-Dividend Date

Related Tickers